Literature DB >> 30532931

Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case.

Fabio Marsico1, Gianluigi Savarese1, Celestino Sardu1, Cristoforo D'Ascia1, Donatella Ruggiero1, Laura Casaretti1, Valentina Parisi1, Francesca Musella1, Elisabetta Pirozzi1, Roberto Formisano1, Teresa Losco1, Pasquale Perrone Filardi1.   

Abstract

Ventricular arrhythmias are frequent in patients with systemic sclerosis and may result in sudden cardiac death. We report the case of a patient with systemic sclerosis and recent syncopes in whom induction of unstable sustained ventricular tachycardia of 2 different morphologies accompanied by syncopal event was demonstrated at the electrophysiological study. He was then implanted a 3rd generation implantable cardioverter defibrillator and remained thereafter asymptomatic. We suggest that aggressive testing is warranted in systemic sclerosis patients with suspected malignant arrhythmias to identify candidates for defibrillator implantation and prevent sudden deaths.

Entities:  

Keywords:  Cardioverter defibrillator; Sudden cardiac death; Systemic sclerosis

Year:  2012        PMID: 30532931      PMCID: PMC6265426          DOI: 10.1016/j.jccase.2012.02.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  25 in total

1.  Heart rate turbulence impairment and ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Piotr Bienias; Michał Ciurzyński; Maria Glińska-Wielochowska; Dariusz Korczak; Agnieszka Kalińska-Bienias; Wiesław Gliński; Piotr Pruszczyk
Journal:  Pacing Clin Electrophysiol       Date:  2010-04-27       Impact factor: 1.976

2.  Electrocardiograms of ninety patients with acrosclerosis and progressive diffuse sclerosis (scleroderma).

Authors:  J H WINDESHEIM; T W PARKIN
Journal:  Circulation       Date:  1958-05       Impact factor: 29.690

3.  De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease.

Authors:  T N James
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

4.  Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis.

Authors:  C Ferri; M Emdin; D Giuggioli; C Carpeggiani; M Maielli; A Varga; C Michelassi; G Pasero; A L'Abbate
Journal:  Br J Rheumatol       Date:  1997-06

Review 5.  Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases.

Authors:  P M Seferović; A D Ristić; R Maksimović; D S Simeunović; G G Ristić; G Radovanović; D Seferović; B Maisch; M Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

6.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

7.  Autonomic dysfunction and microvascular damage in systemic sclerosis.

Authors:  Manuela Di Franco; Michele Paradiso; Valeria Riccieri; Stefania Basili; Antonio Mammarella; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

Review 8.  Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.

Authors:  Steven A Lubitz; Seth H Goldbarg; Davendra Mehta
Journal:  Prog Cardiovasc Dis       Date:  2008 Jul-Aug       Impact factor: 8.194

9.  Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

Authors:  M Abu-Shakra; M B Urowitz; D D Gladman; J Gough
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

10.  Malignant ventricular arrhythmia in systemic sclerosis controlled with an implantable cardioverter defibrillator.

Authors:  V Martinez-Taboada; J Olalla; R Blanco; J Armona; J F Sueiro; V Rodriguez-Valverde
Journal:  J Rheumatol       Date:  1994-11       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.